Neurology 1702 - Neurology Alert - Feb 01, 2013

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Physician Editor
Matthew Fink, MD
Interim Chair and Neurologist-in-Chief
Department of Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Anne Parrish Titzel Professor
Department of Neurology and Neuroscience
Weill Cornell Medical Center

Assistant Editors
Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience
Comprehensive Epilepsy Center
Weill Cornell Medical College

Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Weill Cornell Medical College

Claire Henchcliffe, MD
Associate Professor of Neurology and Neuroscience
Weill Cornell Medical College

Sotirios Keros, MD, PhD
Instructor, Department of Pediatrics
Division of Pediatric Neurology
Weill Cornell Medical College

Author
Halinder S. Mangat, MD
Assistant Professor of Clinical Neurology
Weill Cornell Medical College

Subjects:

  • Switching to a New Epilepsy Drug: Is New Always Better?
  • Myasthenic Antibodies and Disease Phenotype
  • A Trial of Intracranial Pressure Monitoring in Traumatic Brain Injury'” What Do We Do Now?
  • MRI to Visualize Progression in Parkinson's Disease
  • EEG and MRI Findings in Children with Febrile Status Epilepticus

Objectives:

  • discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • discuss the pathogenesis and treatment of pain
  • describe the basic science of brain function
  • discuss new information regarding new drugs for commonly diagnosed neurological conditions and new uses for traditional drugs
  • identify nonclinical issues of importance for the neurologist.

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball , Assistant editors Padmaja Kandula, MD, Michael Rubin, MD, FRCP(C), Sotirios Keros, MD, PhD and Author Halinder S. Mangat, MD, report no financial relationships relevant to this field of study. Assistant editor Claire Henchcliffe, MD reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmith-Kline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.

Copyright 2013 AHC Media. All rights reserved.